REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 161 filers reported holding REATA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,342,704 | +1.0% | 52,400 | -10.0% | 0.00% | 0.0% |
| Q1 2023 | $5,291,544 | +115.0% | 58,200 | -10.2% | 0.00% | +100.0% |
| Q4 2022 | $2,461,752 | +54.7% | 64,800 | +2.4% | 0.00% | +100.0% |
| Q3 2022 | $1,591,000 | -17.3% | 63,300 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $1,924,000 | -7.2% | 63,300 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $2,074,000 | +33.5% | 63,300 | +7.5% | 0.00% | 0.0% |
| Q4 2021 | $1,553,000 | -73.8% | 58,900 | 0.0% | 0.00% | -75.0% |
| Q3 2021 | $5,926,000 | -28.1% | 58,900 | +1.2% | 0.00% | -20.0% |
| Q2 2021 | $8,237,000 | +47.5% | 58,200 | +3.9% | 0.01% | +25.0% |
| Q1 2021 | $5,583,000 | -17.7% | 56,000 | +2.0% | 0.00% | -20.0% |
| Q4 2020 | $6,787,000 | +28.3% | 54,900 | +1.1% | 0.01% | +25.0% |
| Q3 2020 | $5,290,000 | -36.0% | 54,300 | +2.5% | 0.00% | -42.9% |
| Q2 2020 | $8,269,000 | +36.1% | 53,000 | +25.9% | 0.01% | +16.7% |
| Q1 2020 | $6,077,000 | -20.7% | 42,100 | +12.3% | 0.01% | -25.0% |
| Q4 2019 | $7,666,000 | +160.1% | 37,500 | +2.2% | 0.01% | +166.7% |
| Q3 2019 | $2,947,000 | -12.8% | 36,700 | +2.5% | 0.00% | -25.0% |
| Q2 2019 | $3,378,000 | +12.9% | 35,800 | +2.3% | 0.00% | +33.3% |
| Q1 2019 | $2,991,000 | +58.7% | 35,000 | +4.2% | 0.00% | +50.0% |
| Q4 2018 | $1,885,000 | -30.5% | 33,600 | +1.2% | 0.00% | -33.3% |
| Q3 2018 | $2,714,000 | +199.6% | 33,200 | +28.2% | 0.00% | +200.0% |
| Q2 2018 | $906,000 | +122.1% | 25,900 | +30.2% | 0.00% | – |
| Q1 2018 | $408,000 | -27.7% | 19,900 | 0.0% | 0.00% | -100.0% |
| Q4 2017 | $564,000 | -8.9% | 19,900 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $619,000 | +40.7% | 19,900 | +43.2% | 0.00% | 0.0% |
| Q2 2017 | $440,000 | – | 13,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $288,821,000 | 55.24% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 100,000 | $9,970,000 | 15.20% |
| Tolleson Wealth Management, Inc. | 108,000 | $10,768,000 | 3.25% |
| MADDEN SECURITIES Corp | 34,787 | $3,468,000 | 2.03% |
| Biondo Investment Advisors, LLC | 101,204 | $10,090,000 | 2.01% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,027,000 | 1.91% |
| Duquesne Family Office | 749,897 | $74,765,000 | 1.65% |
| Sofinnova Investments, Inc. | 238,520 | $23,780,000 | 1.43% |
| Camber Capital Management LP | 400,000 | $39,880,000 | 1.37% |
| Integral Health Asset Management, LLC | 44,000 | $4,387,000 | 1.25% |